Abstract
Aneurysmal subarachnoid hemorrhage is associated with high rates of morbidity and mortality. In patients who survive the initial hemorrhage, post-hemorrhage complications account for the majority of the morbidity and mortality. Among these complications in the sequelae of the disease, cerebral vasospasm represents a major contributor to the final clinical outcome. Post-hemorrhage neurological deterioration after aneurysmal subarachnoid hemorrhage can often be attributed to delayed cerebral ischemia stemming from prolonged cerebral vasospasm, reduced cerebral blood flow, oxygen delivery, and secondary ischemic injury. As such, the timely detection, screening, diagnosis, and management of cerebral vasospasm can limit delayed cerebral ischemia and improve outcome in patients with subarachnoid hemorrhage. The diagnosis of vasospasm is a multifaceted approach that encompasses the clinical examination in conjunction with supportive neuroradiologic investigations. Among these, transcranial Doppler represents a noninvasive and readily accessible diagnostic tool to screen and diagnose cerebral vasospasm. Furthermore, TCD can also be used in the titration of interventional therapies aimed at improving cerebral blood flow in the setting of vasospasm using induced hypertensive therapy or systemic milrinone. The use of TCD in such a setting requires a multidisciplinary approach that enables experienced personnel to conduct examinations in a reproducible manner upon which therapeutic intervention can be based. This chapter reviews the diagnosis, prevention, and management of delayed cerebral ischemia and arterial vasospasm after aneurysmal subarachnoid hemorrhage.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44–58.
Li K, Barras CD, Chandra RV, et al. A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;126:513–27.
Lerch C, Yonekawa Y, Muroi C, Bjeljac M, Keller E. Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(2):85–92. [Internet] [cited 2016 Jul 6] http://www.ncbi.nlm.nih.gov/pubmed/17099253
Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40(3):994–1025. [Internet] [cited 2015 Mar 2] http://www.ncbi.nlm.nih.gov/pubmed/19164800
Van Gijn J, Rinkel GJE. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124:249–78.
Francoeur CL, Mayer SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care. 2016;20(1):277.
Kumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016;124(5):1257–64.
Rabinstein AA. Critical care of aneurysmal subarachnoid hemorrhage: state of the art. Acta Neurochir Suppl. 2015;120:239–42. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/25366630
Green DM, Burns JD, DeFusco CM. ICU management of aneurysmal subarachnoid hemorrhage. J Intensive Care Med. 2013;28(6):341–54.
Treggiari MM, Walder B, Suter PM, Romand J-A. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg. 2003;98(5):978–84. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/12744357
Wolf S. Routine management of volume status after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):275–80. [Internet] [cited 2015 Mar 2] http://www.ncbi.nlm.nih.gov/pubmed/21748500
Muroi C, Seule M, Mishima K, Keller E. Novel treatments for vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care. 2012;18:119–26.
Treggiari MM. Hemodynamic management of subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):329–35. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/21786046
Treggiari MM, Deem S. Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care. 2009;15(2):83–6. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/19276798
Treggiari MM, Schutz N, Yanez ND, Romand J-A. Role of intracranial pressure values and patterns in predicting outcome in traumatic brain injury: a systematic review. Neurocrit Care. 2007;6(2):104–12. [Internet] [cited 2014 May 11] http://www.ncbi.nlm.nih.gov/pubmed/17522793
Durrant JC, Hinson HE. Rescue therapy for refractory vasospasm after subarachnoid hemorrhage. Curr Neurol Neurosci Rep. 2015;15(2):1–8.
Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care. 2006;4(1):68–76. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/16498198
Nakae R, Yokota H, Yoshida D, Teramoto A. Transcranial doppler ultrasonography for diagnosis of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mean blood flow velocity ratio of the ipsilateral and contralateral middle cerebral arteries. Neurosurgery. 2011;69(4):876–83.
Al-Mufti F, Amuluru K, Damodara N, et al. Novel management strategies for medically-refractory vasospasm following aneurysmal subarachnoid hemorrhage. J Neurol Sci. 2018;390:44–51.
Dabus G, Nogueira RG. Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature. Interv Neurol. 2013;2(1):30–51. [Internet] [cited 2015 Mar 18] http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4031782&tool=pmcentrez&rendertype=abstract
Keyrouz SG, Diringer MN. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11(4):220.
Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KTS. Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth. 2012;109(3):315–29.
Westermaier T, Pham M, Stetter C, et al. Value of transcranial Doppler, perfusion-CT and neurological evaluation to forecast secondary ischemia after aneurysmal SAH. Neurocrit Care. 2013; [Internet] [cited 2014 Apr 29];(Dci). http://www.ncbi.nlm.nih.gov/pubmed/23982597
Meyer R, Deem S, Yanez ND, Souter M, Lam A, Treggiari MM. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage. Neurocrit Care. 2011;14(1):24–36. [Internet] [cited 2015 Mar 20]; http://www.ncbi.nlm.nih.gov/pubmed/20838932
Carrera E, Schmidt JM, Oddo M, et al. Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery. 2009;65(2):316–23. discussion 323-4 [Internet] [cited 2014 May 1] http://www.ncbi.nlm.nih.gov/pubmed/19625911
Purkayastha S, Sorond F. Transcranial Doppler ultrasound: technique and application. Semin Neurol. 2012;32(4):411–20.
White H, Venkatesh B. Applications of transcranial Doppler in the ICU: a review. Intensive Care Med. 2006;32(7):981–94.
Rigamonti A, Ackery A, Baker AJ. Transcranial Doppler monitoring in subarachnoid hemorrhage: a critical tool in critical care. Can J Anesth. 2008;55(2):112–23.
Bertuetti R, Gritti P, Pelosi P, Robba C. How to use cerebral ultrasound in the ICU. Minerva Anestesiol. 2020; [Internet] [cited 2020 Jan 16] http://www.ncbi.nlm.nih.gov/pubmed/31922373
Robba C, Cardim D, Sekhon M, Budohoski K, Czosnyka M. Transcranial Doppler: a stethoscope for the brain-neurocritical care use. J Neurosci Res. 2018;96(4):720.
Sadahiro H, Shirao S, Yoneda H, et al. Decreased flow velocity with transcranial color-coded duplex sonography correlates with delayed cerebral ischemia due to peripheral vasospasm of the middle cerebral artery. J Stroke Cerebrovasc Dis. 2016;25(10):2352–9.
Malhotra K, Conners JJ, Lee VH, Prabhakaran S. Relative changes in transcranial Doppler velocities are inferior to absolute thresholds in prediction of symptomatic vasospasm after subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2014;23(1):31–6. [Internet] [cited 2014 Apr 29] http://www.ncbi.nlm.nih.gov/pubmed/22959107
Gonzalez NR, Boscardin WJ, Glenn T, Vinuela F, Martin NA. Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2007;107(6):1101–12. [Internet] [cited 2014 May 1]; Available from http://www.ncbi.nlm.nih.gov/pubmed/18077946
Marshall SA, Nyquist P, Ziai WC. The role of transcranial Doppler ultrasonography in the diagnosis and management of vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21(2):291–303.
Rasulo FA, De Peri E, Lavinio A. Transcranial Doppler ultrasonography in intensive care. Eur J Anaesthesiol. 2008;25(SUPPL. 42):167–73.
Eddleman CS, Hurley MC, Naidech AM, Batjer HH, Bendok BR. Endovascular options in the treatment of delayed ischemic neurological deficits due to cerebral vasospasm. Neurosurg Focus. 2009;26(3):E6. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/19249962
Dorsch NW. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage part II: management. J Clin Neurosci. 1994;1(2):78–92. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/18638735
Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35(8):1844–51. [Internet] [cited 2015 Mar 20]; quiz 1852; http://www.ncbi.nlm.nih.gov/pubmed/17581487
Lannes M, Teitelbaum J, Corte P, Angle M. Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital Protocol. Neurocrit Care. 2012;16:354–62.
Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery. 2001;48(4):723–8. [Internet] [cited 2015 Mar 20]; http://www.ncbi.nlm.nih.gov/pubmed/11322432 discussion 728-30
Nishiguchi M, Ono S, Iseda K, Manabe H, Hishikawa T, Date I. Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone. Neurosurgery. 2010;66(1):158–64. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/20023546; discussion 164
Romero CM, Morales D, Reccius A, et al. Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;11(2):165–71. [cited 2015 Mar 20]; [Internet] Available from http://www.ncbi.nlm.nih.gov/pubmed/18202923
Schmidt U, Bittner E, Pivi S, Marota JJA. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intra-arterial nicardipine and/or milrinone. Anesth Analg. 2010;110(3):895–902. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/20185665
Fraticelli AT, Cholley BP, Losser M, Saint MJ. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:893–8.
Khajavi K, Ayzman I, Shearer D, et al. Prevention of chronic cerebral vasospasm in dogs with milrinone. Neurosurgery. 1997;40(2):354–62. [Internet] [cited 2015 Mar 20] ; discussion 362-3 http://www.ncbi.nlm.nih.gov/pubmed/9007870
Castro PB, Morales D, Reccius A, et al. Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;11(2):165–71.
Fraticelli AT, Cholley BP, Losser M-R, Saint Maurice J-P, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39(3):893–8. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/18239182
Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S. Milrinone via lumbar subarachnoid catheter for vasospasm after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2014;21(3):470–5. [Internet] [cited 2015 Feb 20] http://www.ncbi.nlm.nih.gov/pubmed/24899113
Hänggi D, Beseoglu K, Turowski B, Steiger HJ. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. Clin Neurol Neurosurg. 2008;110(8):784–90.
Kimball MM, Velat GJ, Hoh BL. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit Care. 2011;15(2):336–41. [Internet] [cited 2015 Mar 20] http://www.ncbi.nlm.nih.gov/pubmed/21761272
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sekhon, M., Ayling, O., Gooderham, P. (2021). Vasospasm After Subarachnoid Hemorrhage. In: Robba, C., Citerio, G. (eds) Echography and Doppler of the Brain. Springer, Cham. https://doi.org/10.1007/978-3-030-48202-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-48202-2_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-48201-5
Online ISBN: 978-3-030-48202-2
eBook Packages: MedicineMedicine (R0)